Concepedia

David Ross Camidge

DR

Statistics

Publications

16

Citations

2.4K

H-Index

12

Active since

2013

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

Yale Cancer Center

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

David Ross Camidge is an author at University of Colorado Denver specializing in oncology, medicine, and malignant neoplasms.

Publications per year

2013–2025

16

Publications

16

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016

David S. Ettinger, Douglas E. Wood, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2016 · 738 citations · Full text

, , +17

Non–Small Cell Lung Cancer, Version 6.2015

David S. Ettinger, Douglas E. Wood, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2015 · 487 citations

, , +17

Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer et al. · The Lancet Oncology · 2016 · 350 citations

, , +14

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 237 citations · Full text

, , +17

Non–Small Cell Lung Cancer, Version 1.2015

David S. Ettinger, Douglas E. Wood, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2014 · 220 citations

, , +17

1–5 of 16